iSOFT Adds New Functionality to UK Laboratory Systems

iSOFT Group LimitediSOFT Group Limited, one of the world's largest healthcare IT companies, will release a series of new functions for its i.Laboratory range of pathology solutions and create a UK-based development team to advance the capability of the laboratory business to meet local needs.

The new modules for i.Laboratory will be available ahead of a major user group forum at the International Convention Centre (ICC) in Birmingham on 10-11 June. As well as a platform for demonstrating the new modules, iSOFT will also provide a forum for customers to inform future developments to realise the benefits of current systems.

To ensure iSOFT's UK customers remain at the forefront of laboratory information system technology (LIS), iSOFT has recently created a local development team in the UK. This will grow rapidly to provide a full laboratory development capacity focused on local requirements.

"These significant developments clearly demonstrate our commitment to LIS customers in the UK and Ireland and to growing our market share," said Adrian Stevens, Managing Director of iSOFT’s UK and Ireland business. "The investment in technology and people is a reflection of the importance of the UK LIS market to iSOFT and we will continue to invest to maintain our leadership position.

"The solutions being developed will provide significant new and updated functionality to meet customer needs and ensure they remain at the forefront of laboratory technology," Stevens said. "Our approach means that users can take immediate advantage of powerful new functionality that will begin their journey on to a technology platform designed for the next phase of the evolution of laboratory services in the UK and globally. This means that even as our customers implement discrete functionality to improve business performance in one area or discipline, they will be building the organisation-wide capability to help deliver a laboratory service of the future. The new offerings will help manage information and reduce the time to turnaround test results and will improve the quality of care and cut costs, which is vital in the current economic climate."

Separately iSOFT has also been awarded a contract by NHS Connecting for Health to develop a solution for GPs and other primary care users to request pathology tests and receive results online. The module will work with all major GP systems and is planned for full release in the second half of 2010.

iSOFT has 150 customers in the NHS and Ireland for its laboratory solutions, giving it a 65% share of the market.

The UK development team will create new functions for all i.Laboratory Apex and i.Laboratory TP users, including:

  • GP Test Results Requesting and Reporting
  • Full word processing and digital dictation for cellular pathology
  • Cancer Histopathology Reporting module
  • Dedicated laboratory interface manager
  • Standardised Business Intelligence
  • Infection control
  • Enhanced disease screening - eGFR, stroke risk calculation and CHD risk calculation
  • Cervical cytology
  • New and improved Graphical User Interface
  • Digital solutions for lab-to-lab interconnectivity
  • Configurable dashboards

"With a large installed base in Europe, iSOFT remains one of the continent's largest providers of laboratory information systems," said Gary Cohen, iSOFT's Executive Chairman and CEO. "These and other developments put us in prime position to capitalise on the growth in this sector and deliver solutions at a local and national level to meet the future needs of public and private laboratory services."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...